ISR Immune System Regulation

Mindre end 1K følgere

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Privatlivspræferencer

ISR Immune System Regulation

ISR Immune System Regulation

ISR's, SARS-CoV-2 dry powder nasal - vaccine booster candidate, ISR52, demonstrates superior immune response, in mouse model challenge studies compared to subcutaneous injection of this vaccine.

ISR, Audiocast with teleconference, Half-year report 2022

ISR: SARS-CoV-2 vaccine study approved by Bangladesh BMRC

Bliv en del af Inderes community

Inderes konto

ISR signs development agreements with Catalent to scale-up its spray-dried nasal vaccine, powder formulation for Phase III.

ISR signs development agreements with Catalent to scale-up its spray-dried nasal vaccine, powder formulation for Phase III.

Delegation from Bangladesh visits ISR for study preparation

Redeye: Redeye Initiates Coverage of ISR Holding

ISR, Audiocast with teleconference, Year-end Report, 2021

ISR's, SARS-CoV-2 dry powder nasal - vaccine booster candidate, ISR52, demonstrates superior immune response, in mouse model challenge studies compared to subcutaneous injection of this vaccine.

ISR, Audiocast with teleconference, Half-year report 2022

ISR: SARS-CoV-2 vaccine study approved by Bangladesh BMRC

Bliv en del af Inderes community

Inderes konto

ISR signs development agreements with Catalent to scale-up its spray-dried nasal vaccine, powder formulation for Phase III.

ISR signs development agreements with Catalent to scale-up its spray-dried nasal vaccine, powder formulation for Phase III.

Delegation from Bangladesh visits ISR for study preparation

Redeye: Redeye Initiates Coverage of ISR Holding

ISR, Audiocast with teleconference, Year-end Report, 2021